Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial

Neurofibromatosis Clinical Trials Consortium

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds